Lenalidomide-C10-OH

• Description:

  Lenalidomide-C10-OH (6a) is an intermediate in the synthesis of INY-03-041[1].

• UNSPSC:

  12352005

• Target:

  Drug Intermediate

• Type:

  Reference compound

• Related Pathways:

  Others

• Field of Research:

  Others

• Assay Protocol:

  https://www.medchemexpress.com/lenalidomide-c10-oh.html

• Purity:

  91.54

• Solubility:

  DMSO : 110 mg/mL (ultrasonic; warming; heat to 80°C)

• Smiles:

  O=C(C(N(CC1=C2C=CC=C1CCCCCCCCCCO)C2=O)CC3)NC3=O

• Molecular Formula:

  C23H32N2O4

• Molecular Weight:

  400.51

• References & Citations:

  [1]You I, et, al. Discovery of an AKT Degrader with Prolonged Inhibition of Downstream Signaling. Cell Chem Biol. 2020 Jan 16;27 (1) :66-73.e7.

• Shipping Conditions:

  Blue Ice

• Storage Conditions:

  -20°C (Powder, sealed storage, away from moisture and light)

• Scientific Category:

  Reference compound1

• Clinical Information:

  No Development Reported

• CAS Number:

  2503018-12-8